Chetan Chandulal Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chetan Chandulal Shah has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Raghu H. Ramakrishnaiah
Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
3 shared publications- S. Bruce Greenberg
University of Arkansas for Medical Sciences
3 shared publications Sadaf T. Bhutta
3 shared publicationsBruce S. Greenberg
2 shared publicationsJohn J. Sarandria
Department of Pediatrics, Nemours Children’s Hospital, Orlando, FL
2 shared publications- Zereen Sarwar
Department of Radiology, College of Medicine, University of Florida, Gainesville, FL 32601, USA
2 shared publications
Latest Publications
- Open Access
- 2 March 2026
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 16
Experience with new technology: Point-of-care magnetic resonance imaging in the neonatal intensive care unit
Neuroimaging is a crucial component of the management of neonates in the neonatal intensive care unit (NICU). Previously, challenges associated with the transport of neonates to a traditional 1.5-3T magnetic resonance imaging (MRI) machine have led to a reliance on ultrasound in the NICU, despite its limitations. Bedside availability of the neonatal MRI system has provided solutions to some of these challenges by decreasing the time of transport, providing continuous monitoring of the neonate, and cable management for lines and leads without an external magnetic field. We present our initial experience with the point-of-care NICU MRI through a clinical case. The point-of-care MRI successfully identified intracranial abnormalities, demonstrating its effectiveness in the NICU.
- 2 March 2026
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 16
Open AccessExperience with new technology: Point-of-care magnetic resonance imaging in the neonatal intensive care unit
Neuroimaging is a crucial component of the management of neonates in the neonatal intensive care unit (NICU). Previously, challenges associated with the transport of neonates to a traditional 1.5-3T magnetic resonance imaging (MRI) machine have led to a reliance on ultrasound in the NICU, despite its limitations. Bedside availability of the neonatal MRI system has provided solutions to some of these challenges by decreasing the time of transport, providing continuous monitoring of the neonate, and cable management for lines and leads without an external magnetic field. We present our initial experience with the point-of-care NICU MRI through a clinical case. The point-of-care MRI successfully identified intracranial abnormalities, demonstrating its effectiveness in the NICU.
- 2 December 2025
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1179) , 468-472
Is exceeding estimated bladder capacity during voiding cystourethrograms harmful?
Objectives: The purpose of this study was to compare the actual bladder capacity of children undergoing voiding cystourethrogram (VCUG) with existing formula-derived estimates and to describe any adverse effects of bladder overdistention during VCUG. Methods: This retrospective study involved review of 884 consecutive VCUG performed over 3 years. Cases with underlying conditions that could artificially increase bladder capacity, such as neurogenic bladders or vesicoureteral reflux, were excluded. Results: Included were 440 normal VCUG procedures. Bladder volumes exceeded the expected bladder capacity set by the American Academy of Pediatrics (AAP) and American College of Radiology in 284 VCUG (65%). Of 261 VCUG performed on children 14 years of age, 7 (50%) exceeded the bladder capacity. No adverse effects were found after the VCUG in the 32 VCUG (7.3%) requiring a contrast volume of more than 2 times the AAP estimates and in the 22 VCUG studies (5%) requiring a contrast volume of more than 3 times the AAP estimates. Conclusion: This study suggests that current guidelines often underestimate bladder capacity, and exceeding the expected bladder capacity appears to be reasonably safe without the occurrence of complications. Advances in knowledge: Current AAP guidelines often underestimate the capacity of the urinary bladder. Exceeding the expected bladder capacity appears to be reasonably safe.
- 2 December 2025
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1179) , 468-472
Is exceeding estimated bladder capacity during voiding cystourethrograms harmful?
Objectives: The purpose of this study was to compare the actual bladder capacity of children undergoing voiding cystourethrogram (VCUG) with existing formula-derived estimates and to describe any adverse effects of bladder overdistention during VCUG. Methods: This retrospective study involved review of 884 consecutive VCUG performed over 3 years. Cases with underlying conditions that could artificially increase bladder capacity, such as neurogenic bladders or vesicoureteral reflux, were excluded. Results: Included were 440 normal VCUG procedures. Bladder volumes exceeded the expected bladder capacity set by the American Academy of Pediatrics (AAP) and American College of Radiology in 284 VCUG (65%). Of 261 VCUG performed on children 14 years of age, 7 (50%) exceeded the bladder capacity. No adverse effects were found after the VCUG in the 32 VCUG (7.3%) requiring a contrast volume of more than 2 times the AAP estimates and in the 22 VCUG studies (5%) requiring a contrast volume of more than 3 times the AAP estimates. Conclusion: This study suggests that current guidelines often underestimate bladder capacity, and exceeding the expected bladder capacity appears to be reasonably safe without the occurrence of complications. Advances in knowledge: Current AAP guidelines often underestimate the capacity of the urinary bladder. Exceeding the expected bladder capacity appears to be reasonably safe.
- Open Access
- 1 January 2023
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 14 (1) , 1-6
Clinically Isolated Syndrome and Frontal Lobe Arteriovenous Malformation Presenting With Behavior Issues
Prevalence of brain arteriovenous malformation ranges from 0.14% to 0.6% according to various estimates. A large number of these patients remain asymptomatic. The most common presentation is due to brain hemorrhage. A 14-year-old girl presented to the pediatrician with erratic behavior issues and hallucinations. She was diagnosed by the pediatrician and mental health facility as having schizophrenia and bipolar disorder. Once she was transferred to our children’s hospital, evaluation by a pediatric neurologist, computed tomography scan, magnetic resonance imaging, and laboratory workup including lumbar puncture confirmed a clinically isolated syndrome and frontal lobe arteriovenous malformation. Frontal lobe lesions including arteriovenous malformation in the frontal lobe can cause psychological symptoms and behavioral issues. We also discuss the differential diagnosis of acute demyelinating syndromes. J Med Cases. 2023;14(1):1-6 doi: https://doi.org/10.14740/jmc4005
- 1 January 2023
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 14 (1) , 1-6
Open AccessClinically Isolated Syndrome and Frontal Lobe Arteriovenous Malformation Presenting With Behavior Issues
Prevalence of brain arteriovenous malformation ranges from 0.14% to 0.6% according to various estimates. A large number of these patients remain asymptomatic. The most common presentation is due to brain hemorrhage. A 14-year-old girl presented to the pediatrician with erratic behavior issues and hallucinations. She was diagnosed by the pediatrician and mental health facility as having schizophrenia and bipolar disorder. Once she was transferred to our children’s hospital, evaluation by a pediatric neurologist, computed tomography scan, magnetic resonance imaging, and laboratory workup including lumbar puncture confirmed a clinically isolated syndrome and frontal lobe arteriovenous malformation. Frontal lobe lesions including arteriovenous malformation in the frontal lobe can cause psychological symptoms and behavioral issues. We also discuss the differential diagnosis of acute demyelinating syndromes. J Med Cases. 2023;14(1):1-6 doi: https://doi.org/10.14740/jmc4005
- Open Access
- 14 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31531
Utility of Gadolinium Use in the Imaging Follow-Up of Nonenhancing Primary Brain Neoplasms in Children
Gadolinium-based contrast agents (GBCAs) have been administered clinically since 1988. They are remarkably well tolerated by children and result in dose-dependent tissue deposition, even in patients with normal renal function. No adverse effects of gadolinium deposition in patients with normal renal function have been established. Given the uncertain effects of gadolinium deposition, we sought to analyze gadolinium use in the imaging follow-up of nonenhancing primary brain neoplasms in children. This retrospective, institutional review board-approved and Health Insurance Portability and Accountability Act-compliant study evaluated pediatric patients who received GBCA in the routine evaluation of brain neoplasms. This special subset included 30 patients (<18 years old) with initially nonenhancing primary intracranial neoplasms who received treatment and follow-up at our institution. Patient data included sex, age from diagnosis to most recent imaging follow-up, number of contrast-enhanced magnetic resonance imaging (MRI) follow-up exams, and histopathology from a biopsy or resection. The group had an expected variety of tumors, including low-grade astrocytomas, dysembryoplastic neuroepithelial tumors, oligodendrogliomas, and teratomas. Half of our patients had tumors of unknown histopathology that were not biopsied or resected. The median age at diagnosis was 8.9 years, the median of four follow-up MRIs per patient, and the median follow-up time of four years. Only one of the 30 patients developed an enhancing focus on follow-up MRI that remained stable and asymptomatic over two years and did not require surgical intervention. Judicious use of GBCA in children, especially when numerous exams over many years are anticipated, is advised given the data regarding soft-tissue deposition. Preliminary results suggest that it may be feasible to omit GBCA from routine follow-ups of initially nonenhancing brain neoplasms.
- 14 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31531
Open AccessUtility of Gadolinium Use in the Imaging Follow-Up of Nonenhancing Primary Brain Neoplasms in Children
Gadolinium-based contrast agents (GBCAs) have been administered clinically since 1988. They are remarkably well tolerated by children and result in dose-dependent tissue deposition, even in patients with normal renal function. No adverse effects of gadolinium deposition in patients with normal renal function have been established. Given the uncertain effects of gadolinium deposition, we sought to analyze gadolinium use in the imaging follow-up of nonenhancing primary brain neoplasms in children. This retrospective, institutional review board-approved and Health Insurance Portability and Accountability Act-compliant study evaluated pediatric patients who received GBCA in the routine evaluation of brain neoplasms. This special subset included 30 patients (<18 years old) with initially nonenhancing primary intracranial neoplasms who received treatment and follow-up at our institution. Patient data included sex, age from diagnosis to most recent imaging follow-up, number of contrast-enhanced magnetic resonance imaging (MRI) follow-up exams, and histopathology from a biopsy or resection. The group had an expected variety of tumors, including low-grade astrocytomas, dysembryoplastic neuroepithelial tumors, oligodendrogliomas, and teratomas. Half of our patients had tumors of unknown histopathology that were not biopsied or resected. The median age at diagnosis was 8.9 years, the median of four follow-up MRIs per patient, and the median follow-up time of four years. Only one of the 30 patients developed an enhancing focus on follow-up MRI that remained stable and asymptomatic over two years and did not require surgical intervention. Judicious use of GBCA in children, especially when numerous exams over many years are anticipated, is advised given the data regarding soft-tissue deposition. Preliminary results suggest that it may be feasible to omit GBCA from routine follow-ups of initially nonenhancing brain neoplasms.
- Open Access
- 11 November 2022
- Published by MDPI AG in Infectious Disease Reports
- Vol. 14 (6) , 837-840
Neuroimaging in Tick Paralysis: Looking Outside the Box
Tick paralysis is a rare but potentially deadly form of muscle paralysis caused by a neurotoxin transmitted through the saliva of gravid, engorged female ticks of various species. Often, there is an initial misdiagnosis or delay in diagnosis due to the rarity of the diagnosis, the obscure location of the tick, and the disease’s clinical similarity to Guillain–Barre syndrome. We report the case of a 4-year-old girl with tick paralysis in whom the tick was not found until 2 days after hospital admission. Upon the review of the imaging, it was discovered that the tick was visible on the MRI of the brain that had been reported as normal.
- 11 November 2022
- Published by MDPI AG in Infectious Disease Reports
- Vol. 14 (6) , 837-840
Open AccessNeuroimaging in Tick Paralysis: Looking Outside the Box
Tick paralysis is a rare but potentially deadly form of muscle paralysis caused by a neurotoxin transmitted through the saliva of gravid, engorged female ticks of various species. Often, there is an initial misdiagnosis or delay in diagnosis due to the rarity of the diagnosis, the obscure location of the tick, and the disease’s clinical similarity to Guillain–Barre syndrome. We report the case of a 4-year-old girl with tick paralysis in whom the tick was not found until 2 days after hospital admission. Upon the review of the imaging, it was discovered that the tick was visible on the MRI of the brain that had been reported as normal.
- Open Access
- 20 August 2021
- Published by Springer Nature in Cureus
- Vol. 13 (8)
Chiari III Malformation on Prenatal and Postnatal Imaging Complicated by Syndrome of Inappropriate Secretion of Anti-diuretic Hormone (SIADH) and Serratia marcescens Meningitis
Among various types of Chiari malformations (CMs), CM III is the most infrequently encountered. In this article, we present a case of CM III with occipital cephalocele appreciated on both prenatal imaging and postnatal follow-up MRI. This case illustrates not only the evolution of this malformation from the in-utero images of fetal MRI to the newborn MRI but also highlights the complications that may accompany this diagnosis such as hydrocephalus and infection. The patient also developed syndrome of inappropriate secretion of anti-diuretic hormone (SIADH). The most current thoughts on the pathophysiology of this entity are also reviewed along with an approach to the differential diagnosis and treatment.
- 20 August 2021
- Published by Springer Nature in Cureus
- Vol. 13 (8)
Open AccessChiari III Malformation on Prenatal and Postnatal Imaging Complicated by Syndrome of Inappropriate Secretion of Anti-diuretic Hormone (SIADH) and Serratia marcescens Meningitis
Among various types of Chiari malformations (CMs), CM III is the most infrequently encountered. In this article, we present a case of CM III with occipital cephalocele appreciated on both prenatal imaging and postnatal follow-up MRI. This case illustrates not only the evolution of this malformation from the in-utero images of fetal MRI to the newborn MRI but also highlights the complications that may accompany this diagnosis such as hydrocephalus and infection. The patient also developed syndrome of inappropriate secretion of anti-diuretic hormone (SIADH). The most current thoughts on the pathophysiology of this entity are also reviewed along with an approach to the differential diagnosis and treatment.
- Open Access
- 29 June 2021
- Published by Springer Nature in Cureus
- Vol. 13 (6) , e16019
Parietal Encephalocele With Fenestrated Superior Sagittal Sinus and Persistent Falcine Sinus
We present a case of a newborn with a fenestrated superior sagittal sinus and persistent falcine sinus with a parietal encephalocele. The patient was born full-term without any associated pregnancy complications other than meconium-stained amniotic fluid at delivery. Following delivery, MRI brain demonstrated midline parietal encephalocele, persistent falcine sinus, fenestration of the superior sagittal sinus at the level of the encephalocele, subependymal heterotopia, and thick tectum. The patient underwent resection and repair on day 2 of life. MRI performed at 15 weeks of life showed a mild increase in the size of lateral ventricles. The patient did not require a ventriculoperitoneal shunt. This is a novel case that provides a valuable contribution to the existing body of literature about congenital encephalocele associated with persistent falcine sinus, fenestrated superior sagittal sinus, subependymal heterotopia, and thick tectum.
- 29 June 2021
- Published by Springer Nature in Cureus
- Vol. 13 (6) , e16019
Open AccessParietal Encephalocele With Fenestrated Superior Sagittal Sinus and Persistent Falcine Sinus
We present a case of a newborn with a fenestrated superior sagittal sinus and persistent falcine sinus with a parietal encephalocele. The patient was born full-term without any associated pregnancy complications other than meconium-stained amniotic fluid at delivery. Following delivery, MRI brain demonstrated midline parietal encephalocele, persistent falcine sinus, fenestration of the superior sagittal sinus at the level of the encephalocele, subependymal heterotopia, and thick tectum. The patient underwent resection and repair on day 2 of life. MRI performed at 15 weeks of life showed a mild increase in the size of lateral ventricles. The patient did not require a ventriculoperitoneal shunt. This is a novel case that provides a valuable contribution to the existing body of literature about congenital encephalocele associated with persistent falcine sinus, fenestrated superior sagittal sinus, subependymal heterotopia, and thick tectum.
- Open Access
- 1 June 2021
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 32, 10-13
Allergic fungal rhinosinusitis presenting with intracranial spread along large sphenoidal emissary foramen
- 1 June 2021
- Published by Elsevier in Medical Mycology Case Reports
- Vol. 32, 10-13
Open AccessAllergic fungal rhinosinusitis presenting with intracranial spread along large sphenoidal emissary foramen
- Open Access
- 5 May 2021
- Published by Springer Nature in Pediatric Radiology
- Vol. 51 (10) , 1895-1906
Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger
Background: Neonates and young children require efficacious magnetic resonance imaging (MRI) examinations but are potentially more susceptible to the short- and long-term adverse effects of gadolinium-based contrast agents due to the immaturity of their body functions. Objective: To evaluate the acute safety and diagnostic efficacy of gadoteridol (ProHance) for contrast-enhanced MRI of the central nervous system (CNS) in children ≤2 years of age. Materials and methods: One hundred twenty-five children ≤2 years old (including 57 children P≤0.006 and 67.5–79.5% vs. 47.0–66.7%; P≤0.011, respectively). Conclusion: Gadoteridol at 0.1 mmol/kg body weight is safe, well tolerated and effective for contrast-enhanced MRI of the CNS in children ≤2 years of age.
- 5 May 2021
- Published by Springer Nature in Pediatric Radiology
- Vol. 51 (10) , 1895-1906
Open AccessSafety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger
Background: Neonates and young children require efficacious magnetic resonance imaging (MRI) examinations but are potentially more susceptible to the short- and long-term adverse effects of gadolinium-based contrast agents due to the immaturity of their body functions. Objective: To evaluate the acute safety and diagnostic efficacy of gadoteridol (ProHance) for contrast-enhanced MRI of the central nervous system (CNS) in children ≤2 years of age. Materials and methods: One hundred twenty-five children ≤2 years old (including 57 children P≤0.006 and 67.5–79.5% vs. 47.0–66.7%; P≤0.011, respectively). Conclusion: Gadoteridol at 0.1 mmol/kg body weight is safe, well tolerated and effective for contrast-enhanced MRI of the CNS in children ≤2 years of age.
- Open Access
- 1 February 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (2) , 262-267
Protrusion of brain stem into oropharynx in newborn: Unusual severe case of Chiari 1 malformation and Clival hypoplasia
- 1 February 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (2) , 262-267
Open AccessProtrusion of brain stem into oropharynx in newborn: Unusual severe case of Chiari 1 malformation and Clival hypoplasia